• / Free eNewsletters & Magazine
  • / My Account
Home>Global $36 Bn Immunoassay Market Analysis & Trends to 2025 - Research and Markets

Global $36 Bn Immunoassay Market Analysis & Trends to 2025 - Research and Markets

Global $36 Bn Immunoassay Market Analysis & Trends to 2025 - Research and Markets

10/04/2017

Global $36 Bn Immunoassay Market Analysis & Trends to 2025 - Research and Markets

The "Global Immunoassay Market Analysis & Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering.

The Global Immunoassay Market is poised to grow at a CAGR of around 8.4% over the next decade to reach approximately $36.1 billion by 2025.

Some of the prominent trends that the market is witnessing include increasing incidences of infectious and chronic devices, surging of ageing population is influencing the growth in the medical device market and rising application in diagnosing drug monitoring tests.

Based on Technology the market is categorized into fluorescence immunoassay (FIA), colorimetric immunoassay (CI), enzyme-linked immunospot (ELISPOT) assay, chemiluminescence immunoassay (CLIA), western blot tests, rapid test, nephelometric immunoassay, polymerase chain reaction (PCR), radioimmunoassay (RIA) and elispot.

By product & services the market is segmented by analyzers, reagents & kits, software and services. By analyzers sub divided into analyzers type and purchase mode. It includes closed-ended systems and open-ended systems. Purchase mode includes outright purchase and reagent rental purchase. Further, reagents & kits sub divided into RIA reagents and kits, elispot reagents and kits, PCR reagents and kits, rapid test reagents and kits, enzyme-linked immunosorbent assay (ELISA) reagents and kits and western blot reagents and kits.

Depending on application the market is classified into autoimmune diseases, cardiology, oncology, thyroid, hematology, allergies, infectious diseases, bone and mineral disorders, neonatal screening, blood screening and other applications.

By end user the market is divided into clinical laboratories research & academic laboratories, blood banks, hospitals, pharmaceutical companies, patient self-testing, ambulatory centers, biotechnology firm and other end users.

©2017 Morningstar Advisor. All right reserved.